JPRN-UMIN000046980
尚未招募
未知
A retrospective epidemiological study of the safety and persistence of immunity to SARS-CoV-2 vaccination in children - IzuNoKuni SARS-CoV-2 Vaccine Study in Children
Juntendo University School of Medicine0 个研究点目标入组 1,700 人2022年2月22日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Children aged 5-11 years living in Izu no Kuni City, Shizuoka
- 发起方
- Juntendo University School of Medicine
- 入组人数
- 1700
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •Children presenting with fever at the time of vaccination The child is suffering from a serious acute illness. Children with conditions that make them inappropriate for vaccination. Any other person who is judged by the principal investigator to be unsuitable as a research subject.
结局指标
主要结局
未指定
相似试验
已完成
不适用
A historical cohort study to examine the safety and efficacy of olaparib maintenance therapy after initial treatment for advanced ovarian cancerJPRN-UMIN000043474Japanese Gynecologic Oncology Group (JGOG)300
进行中（未招募）
1 期
Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839Relapsing-remitting multiple sclerosisMedDRA version: 18.0Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2014-003265-19-PLGenzyme Corporation168
进行中（未招募）
1 期
A long-term follow-up study to evaluate the safety and efficacy of retinal gene therapy in subjects with Choroideremia previously treated with AAV2-REP1 and in subjects with X-Linked Retinitis Pigmentosa previously treated with AAV8-RPGR in an antecedent studyEUCTR2017-003104-42-DEightstaRx Ltd (A Biogen Company)330
进行中（未招募）
1 期
A long-term follow-up study to evaluate the safety and efficacy of retinal gene therapy in subjects with Choroideremia previously treated with AAV2- REP1 in an antecedent study and in subjects with X-Linked Retinitis Pigmentosa previously treated with AAV8-RPGR in an antecedent studyChoroideremia (CHM)X-Linked Retinitis Pigmentosa (XLRP)MedDRA version: 20.1Level: LLTClassification code 10008791Term: ChoroideremiaSystem Organ Class: 100000004853MedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2017-003104-42-DKightstaRx Ltd (A Biogen Company)330
进行中（未招募）
1 期
A long-term follow-up study to evaluate the safety and efficacy of retinal gene therapy in subjects with Choroideremia previously treated in an antecedent studyChoroideremia (CHM)Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2017-003104-42-NLightstaRx Ltd167